Space

Events and Webinars

ISPOR Europe 2024

17-20 November 2024 Barcelona, Spain

Meet Fortrea’s Market Access Consulting & HEOR team at ISPOR Europe 2024

Meet us in Barcelona, Spain from November 17-20 as we take part in the leading European conference for health economics and outcomes research (HEOR).

While at ISPOR Europe 2024, we invite you to meet with our team of Market Access Consulting & HEOR professionals who will be on hand to discuss the key challenges you are facing in market access, pricing and health economics. With Fortrea’s market access and HEOR expertise, we identify evidence gaps and design and execute custom projects to support your product and stakeholder needs. Rely on us to help ensure you are equipped to demonstrate the full value of your product across the audiences of regulators, providers, payers, policymakers and patients.

Stop by any one of the six posters Fortrea is presenting and connect with our subject matter experts. We look forward to seeing you there!

Featured presentations

18 Nov | 16:00 - 19:00

Use of External Control Arms in Reimbursement Submissions: A Review of CAR-T Appraisals by NICE and CDA

Comentale S12, Messina P1, Daniel S3, Jin G2, Szende A2 1Fortrea, Milan, Italy, 2Fortrea, Maidenhead, UK, 3Fortrea, Tel Aviv, Israel

Poster Session 2
item0
S Comentale
18 Nov | 16:00 - 19:00

Emerging Trends in the Adoption of Alternative Financing Models for Advanced Therapy Medicinal Products: A Scoping Review

Cardoso A1, Wallace M2 1Fortrea, Lisbon, Portugal, 1Fortrea, Maidenhead, UK

Poster Session 2
item0
A Cardoso
item1
M Wallace
19 Nov | 10:30 - 13:30

Socioeconomic Indicators of Self-Reported Health Based on EQ-5D-5L: Results From General Population Surveys in England and Spain

Szende A1, Feng YS2, Janssen MF3 1Fortrea, York, North Yorkshire, UK, 2Medical University of Tübingen, Tübingen, Baden-Württemberg, Germany, 3The EuroQol Group, Rotterdam, Rotterdam, Netherlands

Poster Session 3
item0
A Szende
19 Nov | 10:30 - 13:30

Setting Diversity Enrollment Goals in Clinical Trials Based on Real-World Data: Potential Challenges With Multi-Country Requirements

Plante K1, Kiri V2, Knight T3, Howell A4 1Fortrea Inc., Gaithersburg, MD, USA, 2Fortrea Inc., Guildford, SRY, UK, 3Fortrea Inc., Princeton, NJ, USA, 4Fortrea Inc., London, London, UK

Poster Session 3
item0
K Plante
19 Nov | 16:00 - 19:00

Use of Secondary Real-World Data From the United States to Fulfill European Medicines Agency Post Authorization Requirement

Knight T1, Plante K2, Ruggieri A3 1Fortrea Inc., Greenwood, IN, USA, 2Fortrea Inc., Guildford, SRY, UK, 3Angelini Pharma S.p.A, Rome, Italy

Poster Session 4
item0
K Plante
19 Nov | 16:00 - 19:00

A Framework for Assessing the Viability of an Externally Controlled Arm for a Single-Arm Trial

Kiri V1, Anastassopoulos KP2 1Fortrea Inc., Guildford, SRY, UK, 2Fortrea, Inc., Gaithersburg, MD, USA

Poster Session 4
item0
K Anastassopoulos